skip to main content
Refinado por: Base de dados/Biblioteca: Oxford Journals remover Base de dados/Biblioteca: ScienceDirect remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy
Material Type:
Artigo
Adicionar ao Meu Espaço

The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy

Bonanno, L. ; Costa, C. ; Majem, M. ; Favaretto, A. ; Rugge, M. ; Rosell, R.

Annals of oncology, 2013-04, Vol.24 (4), p.1130-1132 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

2
Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study
Material Type:
Artigo
Adicionar ao Meu Espaço

Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study

Gridelli, C. ; Morgillo, F. ; Favaretto, A. ; de Marinis, F. ; Chella, A. ; Cerea, G. ; Mattioli, R. ; Tortora, G. ; Rossi, A. ; Fasano, M. ; Pasello, G. ; Ricciardi, S. ; Maione, P. ; Di Maio, M. ; Ciardiello, F.

Annals of oncology, 2011-07, Vol.22 (7), p.1528-1534 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

3
Compliance to diagnostic and therapeutic pathways and innovative drug recommendations in advanced non-small cell lung cancer: preliminary results from the MOST study
Material Type:
Artigo
Adicionar ao Meu Espaço

Compliance to diagnostic and therapeutic pathways and innovative drug recommendations in advanced non-small cell lung cancer: preliminary results from the MOST study

Pasello, G. ; Vicario, G. ; Gori, S. ; Zustovich, F. ; Bonetti, A. ; Rosetti, F. ; Favaretto, A. ; Oniga, F. ; Bria, E. ; Toso, S. ; Boccalon, M. ; Oliani, C. ; Palazzolo, G. ; Frega, S. ; Basso, M. ; Pertile, P. ; Bortolami, A. ; Verrienti, R. ; Scanni, R. ; Conte, P.

Annals of oncology, 2017-10, Vol.28, p.vi57-vi57 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

4
Negative prognostic factors and resulting clinical outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) included in the Italian nivolumab expanded access program (EAP)
Material Type:
Artigo
Adicionar ao Meu Espaço

Negative prognostic factors and resulting clinical outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) included in the Italian nivolumab expanded access program (EAP)

Bracarda, S. ; Galli, L. ; Maruzzo, M. ; Lo Re, G. ; Buti, S. ; Favaretto, A. ; Costanzo, F.D. ; Sacco, C. ; Merlano, M. ; Mucciarini, C. ; Zafarana, E. ; Romito, S. ; Maestri, A. ; Giannitto Giorgio, C. ; Ionta, M.T. ; Turci, D. ; De Giorgi, U. ; Procopio, G. ; Cortesi, E. ; Porta, C.

Annals of oncology, 2017-09, Vol.28, p.v314-v314 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

5
Are PubMed alone and English literature only enough for a meta-analysis?
Material Type:
Artigo
Adicionar ao Meu Espaço

Are PubMed alone and English literature only enough for a meta-analysis?

Zheng, B. ; Zheng, W. ; Zhu, Y. ; Guo, C. ; Wu, W. ; Chen, C.

Annals of oncology, 2013-04, Vol.24 (4), p.1130-1130 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

6
Symptomatic Toxicities Experienced During Anti-Cancer Treatment: Comparison of Patients' and Physicians' Reporting in Three Randomized Controlled Trials (Rcts)
Material Type:
Artigo
Adicionar ao Meu Espaço

Symptomatic Toxicities Experienced During Anti-Cancer Treatment: Comparison of Patients' and Physicians' Reporting in Three Randomized Controlled Trials (Rcts)

Di Maio, M. ; Piccirillo, M.C. ; Daniele, G. ; Nuzzo, F. ; Gridelli, C. ; Gebbia, V. ; Ciardiello, F. ; De Placido, S. ; Ceribelli, A. ; Favaretto, A. ; De Matteis, A. ; Feld, R. ; Butts, C.A. ; Leighl, N.B. ; Morabito, A. ; Bryce, J. ; Signoriello, S. ; Gallo, C. ; Perrone, F.

Annals of oncology, 2014-09, Vol.25, p.iv517 [Periódico revisado por pares]

Texto completo disponível

7
Epidermal Growth Factor Receptor (Egfr) and Abcg2 Polymorphisms and Treatment Outcome in the Randomized Phase III Torch Trial in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients
Material Type:
Artigo
Adicionar ao Meu Espaço

Epidermal Growth Factor Receptor (Egfr) and Abcg2 Polymorphisms and Treatment Outcome in the Randomized Phase III Torch Trial in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients

Liu, G. ; Di Maio, M. ; Tsao, M. ; Cheng, D. ; Chen, Z. ; Wierzbicki, R. ; Riccardi, F. ; Spatafora, M. ; Adamo, V. ; Favaretto, A. ; Bianco, R. ; Gregg, R.W. ; Costanzo, R. ; Signoriello, S. ; Butts, C.A. ; Ciardiello, F. ; Feld, R. ; Gallo, C. ; Gridelli, C. ; Perrone, F.

Annals of oncology, 2014-09, Vol.25, p.iv438 [Periódico revisado por pares]

Texto completo disponível

8
1250PEPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND ABCG2 POLYMORPHISMS AND TREATMENT OUTCOME IN THE RANDOMIZED PHASE III TORCH TRIAL IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
Material Type:
Artigo
Adicionar ao Meu Espaço

1250PEPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND ABCG2 POLYMORPHISMS AND TREATMENT OUTCOME IN THE RANDOMIZED PHASE III TORCH TRIAL IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS

Liu, G. ; Di Maio, M. ; Tsao, M. ; Cheng, D. ; Chen, Z. ; Wierzbicki, R. ; Riccardi, F. ; Spatafora, M. ; Adamo, V. ; Favaretto, A. ; Bianco, R. ; Gregg, R.W. ; Costanzo, R. ; Signoriello, S. ; Butts, C.A. ; Ciardiello, F. ; Feld, R. ; Gallo, C. ; Gridelli, C. ; Perrone, F.

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv438-iv438 [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

9
1480OSYMPTOMATIC TOXICITIES EXPERIENCED DURING ANTI-CANCER TREATMENT: COMPARISON OF PATIENTS' AND PHYSICIANS' REPORTING IN THREE RANDOMIZED CONTROLLED TRIALS (RCTS)
Material Type:
Artigo
Adicionar ao Meu Espaço

1480OSYMPTOMATIC TOXICITIES EXPERIENCED DURING ANTI-CANCER TREATMENT: COMPARISON OF PATIENTS' AND PHYSICIANS' REPORTING IN THREE RANDOMIZED CONTROLLED TRIALS (RCTS)

Di Maio, M. ; Piccirillo, M.C. ; Daniele, G. ; Nuzzo, F. ; Gridelli, C. ; Gebbia, V. ; Ciardiello, F. ; De Placido, S. ; Ceribelli, A. ; Favaretto, A. ; De Matteis, A. ; Feld, R. ; Butts, C.A. ; Leighl, N.B. ; Morabito, A. ; Bryce, J. ; Signoriello, S. ; Gallo, C. ; Perrone, F.

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv517-iv517 [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

10
A multicenter, randomised, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients (pts). The STAD-1 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

A multicenter, randomised, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients (pts). The STAD-1 trial

Daniele, G. ; Morabito, A. ; Favaretto, A. ; Filipazzi, V. ; Rossi, A. ; Gebbia, V. ; Castiglione, F. ; Cavanna, L. ; Maiello, E. ; Valmadre, G. ; Costanzo, R. ; Manzo, A. ; Bonanno, L. ; Piazza, E. ; Maione, P. ; Mancuso, G. ; Di Maio, M. ; Piccirillo, M.C. ; Gallo, C. ; Perrone, F. ; Gridelli, C.

Annals of oncology, 2015-10, Vol.26, p.vi73 [Periódico revisado por pares]

Texto completo disponível

Buscando em bases de dados remotas. Favor aguardar.